Literature DB >> 28042406

A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN).

Nabil Al Macki1, Ismail Al Rashdi2.   

Abstract

Mutations in the C19orf12 gene are known to cause mitochondrial membrane protein-associated neurodegeneration (MPAN), which is a neurodegeneration with brain iron accumulation (NBIA) type 4 disorder. To the best of our knowledge, this is the first report of a genetically confirmed case of MPAN from Oman. A novel homozygous deletion of exon 2 of the C19orf12 gene was confirmed on the proband, a seven-year-old girl, who presented with gait instability. Brain magnetic resonance imaging showed iron deposition on the basal ganglia. This report highlights the importance of genetic testing of such a clinically and genetically heterogeneous condition among a population with a high consanguinity rate. To overcome the diagnostic difficulty, implementation of a cost-effective approach to perform cascade screening of carriers at risk is needed as well as programs to address risky consanguineous marriages.

Entities:  

Keywords:  C19orf12 protein, human; Genetics; Neurodegeneration with brain iron accumulation (NBIA)

Year:  2017        PMID: 28042406      PMCID: PMC5187394          DOI: 10.5001/omj.2017.12

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  7 in total

1.  New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.

Authors:  Penelope Hogarth; Allison Gregory; Michael C Kruer; Lynn Sanford; Wendy Wagoner; Marvin R Natowicz; Robert T Egel; S H Subramony; Jennifer G Goldman; Elizabeth Berry-Kravis; Nicola C Foulds; Simon R Hammans; Isabelle Desguerre; Diana Rodriguez; Callum Wilson; Andrea Diedrich; Sarah Green; Huong Tran; Lindsay Reese; Randall L Woltjer; Susan J Hayflick
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

2.  Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.

Authors:  Monika B Hartig; Arcangela Iuso; Tobias Haack; Tomasz Kmiec; Elzbieta Jurkiewicz; Katharina Heim; Sigrun Roeber; Victoria Tarabin; Sabrina Dusi; Malgorzata Krajewska-Walasek; Sergiusz Jozwiak; Maja Hempel; Juliane Winkelmann; Matthias Elstner; Konrad Oexle; Thomas Klopstock; Wolfgang Mueller-Felber; Thomas Gasser; Claudia Trenkwalder; Valeria Tiranti; Hans Kretzschmar; Gerd Schmitz; Tim M Strom; Thomas Meitinger; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

Review 3.  Childhood disorders of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Manju A Kurian; Alasdair McNeill; Jean-Pierre Lin; Eamonn R Maher
Journal:  Dev Med Child Neurol       Date:  2011-05       Impact factor: 5.449

4.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

Authors:  B Zhou; S K Westaway; B Levinson; M A Johnson; J Gitschier; S J Hayflick
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

5.  Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* time.

Authors:  R Fermin-Delgado; P Roa-Sanchez; H Speckter; E Perez-Then; D Rivera-Mejia; B Foerster; P Stoeter
Journal:  Clin Neuroradiol       Date:  2012-01-19       Impact factor: 3.649

6.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.

Authors:  A McNeill; D Birchall; S J Hayflick; A Gregory; J F Schenk; E A Zimmerman; H Shang; H Miyajima; P F Chinnery
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

Review 7.  Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations.

Authors:  Susanne A Schneider; John Hardy; Kailash P Bhatia
Journal:  Mov Disord       Date:  2011-10-26       Impact factor: 10.338

  7 in total
  1 in total

1.  A new NBIA patient from Turkey with homozygous C19ORF12 mutation.

Authors:  Çiğdem Seher Kasapkara; Leyla Tümer; Allison Gregory; Fatih Ezgü; Aslı İnci; Betül Emine Derinkuyu; Rachel Fox; Caleb Rogers; Susan Hayflick
Journal:  Acta Neurol Belg       Date:  2018-10-08       Impact factor: 2.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.